GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » Price-to-Tangible-Book

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Price-to-Tangible-Book : 1.96 (As of Dec. 15, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-12-15), Shanghai Kaibao Pharmaceutical Co's share price is ¥6.92. Shanghai Kaibao Pharmaceutical Co's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was ¥3.52. Hence, Shanghai Kaibao Pharmaceutical Co's Price to Tangible Book Ratio of today is 1.96.

The historical rank and industry rank for Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300039' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.5   Med: 2.2   Max: 6.79
Current: 1.96

During the past 13 years, Shanghai Kaibao Pharmaceutical Co's highest Price to Tangible Book Ratio was 6.79. The lowest was 1.50. And the median was 2.20.

SZSE:300039's Price-to-Tangible-Book is ranked better than
60.33% of 842 companies
in the Drug Manufacturers industry
Industry Median: 2.405 vs SZSE:300039: 1.96

A closely related ratio is called PB Ratio. As of today, Shanghai Kaibao Pharmaceutical Co's share price is ¥6.92. Shanghai Kaibao Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Sep. 2024 was ¥3.68. Hence, Shanghai Kaibao Pharmaceutical Co's P/B Ratio of today is 1.88.


Shanghai Kaibao Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kaibao Pharmaceutical Co Price-to-Tangible-Book Chart

Shanghai Kaibao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.07 2.03 2.16 2.27 1.74

Shanghai Kaibao Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 1.74 1.71 1.68 1.81

Competitive Comparison of Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book falls into.



Shanghai Kaibao Pharmaceutical Co Price-to-Tangible-Book Calculation

Shanghai Kaibao Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=6.92/3.522
=1.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Shanghai Kaibao Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kaibao Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401
Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.
Executives
Liu Shao Yong Supervisors
Ren Li Wang Secretary Dong
Zhang Tao Executives
Mu Jing Wei Director
Li Xiu Hai Directors, executives
Zhang Lian Xin Supervisors
Han Jing Independent director
Wang Guo Ming Directors, executives
Wang Chong Bang Executives
Liu Yi Shan Director
Li Qing Wei Independent director
Mu Lai An Director
Zhu Ying Jun Executives
Chang Qing Ling Supervisors
Zhang Peng Director

Shanghai Kaibao Pharmaceutical Co Headlines

No Headlines